Biomarkers of Vascular Calcification and Mortality in Patients with ESRD

被引:72
作者
Scialla, Julia J. [1 ]
Kao, W. H. Linda [2 ,4 ]
Crainiceanu, Ciprian [3 ]
Sozio, Stephen M. [4 ]
Oberai, Pooja C. [2 ]
Shafi, Tariq [4 ]
Coresh, Josef [2 ]
Powe, Neil R. [5 ,6 ]
Plantinga, Laura C. [7 ]
Jaar, Bernard G. [4 ,8 ]
Parekh, Rulan S. [2 ,4 ,9 ,10 ]
机构
[1] Univ Miami, Dept Med, Miami, FL USA
[2] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA
[3] Johns Hopkins Univ, Dept Biostat, Baltimore, MD 21205 USA
[4] Johns Hopkins Univ, Dept Med, Baltimore, MD USA
[5] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA
[6] Univ Calif San Francisco, San Francisco, CA 94143 USA
[7] Emory Univ, Dept Epidemiol, Atlanta, GA 30322 USA
[8] Nephrol Ctr Maryland, Baltimore, MD USA
[9] Univ Hlth Network, Hosp Sick Children, Toronto, ON, Canada
[10] Univ Toronto, Toronto, ON, Canada
来源
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2014年 / 9卷 / 04期
基金
美国医疗保健研究与质量局; 美国国家卫生研究院;
关键词
vascular calcification; end-stage renal disease; diabetes; CHRONIC KIDNEY-DISEASE; MATRIX GLA PROTEIN; FETUIN-A LEVELS; FIBROBLAST GROWTH FACTOR-23; CARDIOVASCULAR-DISEASE; PLASMA OSTEOPROTEGERIN; ARTERY CALCIFICATION; AORTIC CALCIFICATION; DEFICIENT MICE; SERUM;
D O I
10.2215/CJN.05450513
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
BackgroundVascular calcification is common among patients undergoing dialysis and is associated with mortality. Factors such as osteoprotegerin (OPG), osteopontin (OPN), bone morphogenic protein-7 (BMP-7), and fetuin-A are involved in vascular calcification.Design, setting, participants, & measurementsOPG, OPN, BMP-7, and fetuin-A were measured in blood samples from 602 incident dialysis patients recruited from United States dialysis centers between 1995 and 1998 as part of the Choices for Healthy Outcomes In Caring for ESRD Study. Their association with all-cause and cardiovascular mortality were assessed using Cox proportional hazards models adjusted for demographic characteristics, comorbidity, serum phosphate, and calcium. An interaction with diabetes was tested because of its known association with vascular calcification. Predictive accuracy of selected biomarkers was explored by C-statistics in nested models with training and validation subcohorts.ResultsHigher OPG and lower fetuin-A levels were associated with higher mortality over up to 13 years of follow-up (median, 3.4 years). The adjusted hazard ratios (HR) for highest versus lowest tertile were 1.49 (95% confidence interval [95% CI], 1.08 to 2.06) for OPG and 0.69 (95% CI, 0.52 to 0.92) for fetuin-A. In stratified models, the highest tertile of OPG was associated with higher mortality among patients without diabetes (HR, 2.42; 95% CI, 1.35 to 4.34), but not patients with diabetes (HR, 1.26; 95% CI, 0.82 to 1.93; P for interaction=0.001). In terms of cardiovascular mortality, higher fetuin-A was associated with lower risk (HR, 0.85 per 0.1 g/L: 95% CI, 0.75 to 0.96). In patients without diabetes, higher OPG was associated with greater risk (HR for highest versus lowest tertile, 2.91; 95% CI, 1.06 to 7.99), but not in patients with diabetes or overall. OPN and BMP-7 were not independently associated with outcomes overall. The addition of OPG and fetuin-A did not significantly improve predictive accuracy of mortality.ConclusionsOPG and fetuin-A may be risk factors for all-cause and cardiovascular mortality in patients undergoing dialysis, but do not improve risk prediction.
引用
收藏
页码:745 / 755
页数:11
相关论文
共 55 条
[1]  
[Anonymous], USRDS 2011 ANN DAT R
[2]   Association of plasma osteopontin levels with coronary calcification evaluated by tomographic coronary calcium scoring [J].
Aryan, Muhammedullah ;
Kepez, Alper ;
Atalar, Enver ;
Hazirolan, Tuncay ;
Haznedaroglu, Ibrahim ;
Akata, Deniz ;
Ozer, Necla ;
Aksoyek, Serdar ;
Ovunc, Kanan ;
Ozmen, Ferhan .
JOURNAL OF BONE AND MINERAL METABOLISM, 2009, 27 (05) :591-597
[3]   Coronary calcification in hemodialysis patients: The contribution of traditional and uremia-related risk factors [J].
Barreto, DV ;
Barreto, FC ;
Carvalho, AB ;
Cuppari, L ;
Cendoroglo, M ;
Draibe, SA ;
Moyses, RMA ;
Neves, KR ;
Jorgetti, V ;
Blair, A ;
Guiberteau, R ;
Canziani, MEF .
KIDNEY INTERNATIONAL, 2005, 67 (04) :1576-1582
[4]   Activation of Vascular Bone Morphogenetic Protein Signaling in Diabetes Mellitus [J].
Bostroem, Kristina I. ;
Jumabay, Medet ;
Matveyenko, Aleksey ;
Nicholas, Susanne B. ;
Yao, Yucheng .
CIRCULATION RESEARCH, 2011, 108 (04) :446-U123
[5]   osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification [J].
Bucay, N ;
Sarosi, I ;
Dunstan, CR ;
Morony, S ;
Tarpley, J ;
Capparelli, C ;
Scully, S ;
Tan, HL ;
Xu, WL ;
Lacey, DL ;
Boyle, WJ ;
Simonet, WS .
GENES & DEVELOPMENT, 1998, 12 (09) :1260-1268
[6]   Low turnover osteodystrophy and vascular calcification are amenable to skeletal anabolism in an animal model of chronic kidney disease and the metabolic syndrome [J].
Davies, MR ;
Lund, RJ ;
Mathew, S ;
Hruska, KA .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (04) :917-928
[7]   FGF23 is independently associated with vascular calcification but not bone mineral density in patients at various CKD stages [J].
Desjardins, L. ;
Liabeuf, S. ;
Renard, C. ;
Lenglet, A. ;
Lemke, H-D. ;
Choukroun, G. ;
Drueke, T. B. ;
Massy, Z. A. .
OSTEOPOROSIS INTERNATIONAL, 2012, 23 (07) :2017-2025
[8]   FGF23 induces left ventricular hypertrophy [J].
Faul, Christian ;
Amaral, Ansel P. ;
Oskouei, Behzad ;
Hu, Ming-Chang ;
Sloan, Alexis ;
Isakova, Tamara ;
Gutierrez, Orlando M. ;
Aguillon-Prada, Robier ;
Lincoln, Joy ;
Hare, Joshua M. ;
Mundel, Peter ;
Morales, Azorides ;
Scialla, Julia ;
Fischer, Michael ;
Soliman, Elsayed Z. ;
Chen, Jing ;
Go, Alan S. ;
Rosas, Sylvia E. ;
Nessel, Lisa ;
Townsend, Raymond R. ;
Feldman, Harold I. ;
Sutton, Martin St. John ;
Ojo, Akinlolu ;
Gadegbeku, Crystal ;
Di Marco, Giovana Seno ;
Reuter, Stefan ;
Kentrup, Dominik ;
Tiemann, Klaus ;
Brand, Marcus ;
Hill, Joseph A. ;
Moe, Orson W. ;
Kuro-o, Makoto ;
Kusek, John W. ;
Keane, Martin G. ;
Wolf, Myles .
JOURNAL OF CLINICAL INVESTIGATION, 2011, 121 (11) :4393-4408
[9]   OSTEOPONTIN IS ELEVATED DURING NEOINTIMA FORMATION IN RAT ARTERIES AND IS A NOVEL COMPONENT OF HUMAN ATHEROSCLEROTIC PLAQUES [J].
GIACHELLI, CM ;
BAE, N ;
ALMEIDA, M ;
DENHARDT, DT ;
ALPERS, CE ;
SCHWARTZ, SM .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (04) :1686-1696
[10]   Osteopontin: a versatile regulator of inflammation and biomineralization [J].
Giachelli, CM ;
Steitz, S .
MATRIX BIOLOGY, 2000, 19 (07) :615-622